Skip to content

Birth Cohort Study of China Medical University

Birth Cohort Study of China Medical University in Shenyang

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03561766
Enrollment
1000
Registered
2018-06-19
Start date
2018-06-15
Completion date
2037-06-30
Last updated
2019-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Maternal Age Pregnancy, Overweight and Obesity, Scarred Uterus, Twin; Complicating Pregnancy

Brief summary

The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology. Data are collected regarding environmental factors, family and lifestyle, clinical experimental outcomes and imaging results of pregnant women and children from birth to 18 years old. Biological samples including blood and tissue samples are also collected from the children and their parents.

Detailed description

Early life phase (fetal and infant) is a critical period for the development of health and disease in a person's life. Many adult chronic diseases, such as diabetes, cardiovascular and cerebrovascular diseases, all come from the exposure of negative environmental and behavioral factors during this period. By collecting the lifestyle data and clinical data of pregnant women at different periods, the appropriate indicators are anticipated to be selected to predict and evaluate the outcome of pregnancy and the health of the mothers and children in the long term. The status of overweight and obesity of children in Shenyang and its surrounding areas are anticipated to be analyzed by descriptive and etiological analysis through collecting the lifestyle data and clinical data of different periods of pregnant women and the lifestyle data of different developmental stages of children.

Interventions

None listed

Sponsors

Shengjing Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Pregnant women, \<13 gestational weeks 2. Permanent residents or families intended to remain in Shenyang and surrounding areas 3. Pregnant women who are planned to be examined and delivered in Shengjing Hospital.

Exclusion criteria

1. Pregnant women who refuse to take part in the study 2. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.

Design outcomes

Primary

MeasureTime frameDescription
Result of Non-invasive Prenatal TestingFrom 12 to 22 weeks of gestational ageincluding singleton and twin pregnancy
Change of biometric parameter in centimeter of fetuses at the thirteenth week of gestational ageAt every week from the thirteenth week of gestational age to delivery of babiesIncluding head circumference, abdominal circumference, biparietal diameter, femur length of singleton and twin pregnancy
Weight in kilogram of neonateAt birth of neonateIncluding singleton and twin pregnancy measured by nurses
Gene expression of husbands of pregnancy womenAt 13 weeks of gestational ageDNA methylation, histone acetylation etc. assessed by analyses of blood
Change of gene expression of pregnancy womenAt 13, 26 and 34 weeks of gestational ageDNA methylation, histone acetylation etc. assessed by analyses of blood

Secondary

MeasureTime frameDescription
Height in centimeter changes during childhoodAge at 1 year, 3 years, 6 years, 9 years, 12 years, 15 years and 18 yearsMeasured by nurses in clinic
Weight in kilogram changes during childhoodAge at 1 year, 3 years, 6 years, 9 years, 12 years, 15 years and 18 yearsMeasured by nurses in clinic
Change of gene expression during childhoodAge at 1 year, 3 years, 6 years, 9 years, 12 years, 15 years and 18 yearsDNA methylation, histone acetylation etc. assessed by analyses of blood
Change of intestinal flora during early childhoodAge at 1 year, 3 years, 6 years, 9 years, 12 years, 15 years and 18 yearsAssessed by analyses of stool samples

Countries

China

Contacts

Primary ContactCaixia Liu
liucx1716@163.com86-18902451716
Backup ContactShaojiang Liu
liushaojiang1995@qq.com86-18002454803

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026